2025 Employer Health Benefits Survey

This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, worker contributions, cost-sharing provisions, offer rates, and more. This year’s report also looks at how employers are approaching coverage of GLP-1 drugs for weight loss, including their concerns about utilization and cost.

Read More

Poll: Most Republicans Do Not Trust CDC On Bird Flu

As bird flu continues to circulate among animals in the U.S. with some human cases, about six in 10 (58%) people overall have at least “a fair amount” of trust in the Centers for Disease Control and Prevention (CDC) to provide reliable information about bird flu, though only 21% have a “great deal of trust,”…More

Read More

KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease

KalVista Pharmaceuticals’ Ekterly is now FDA approved for treating acute swelling attacks from hereditary angioedema. The KalVista tablet provides an alternative to injectable or infused HAE medications from companies such as Takeda Pharmaceutical and CSL Behring. The post KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease appeared first on MedCity…

Read More

The Surprising Rivalries-Turned-Friendships That Are Shaping Diabetes Technology

Over the past decade, Abbott and Dexcom — the two largest makers of continuous glucose monitors — have been teaming up with medical device companies that sell automated insulin delivery systems. Industry experts think these partnerships are smart moves to stay relevant in the rapidly-developing diabetes care space. The post The Surprising Rivalries-Turned-Friendships That Are…

Read More